Non Salt Form
GLP-1 (Compound 2 Receptor) are agonist medications used to treat obesity and aid in dramatic weight loss. GLP-1 are both once-weekly injections that require no change in diet or lifestyle to produce weight loss results of greater than 50 lb in as little as 6 months. When used along with an individualized low-calorie, low-carb diet, and exercise program to help with weight loss, overweight adults who may also have high blood pressure, diabetes, or high cholesterol see significant progress across all health markers. GLP-1 injections are a class of medications called glucagon-like-peptide-1 (GLP-1) agonists, although GLP-1 (Compound 2 Receptor) has enhanced effects as a glucose-dependent insulinotropic polypeptide (GIP) agonist that produce more drastic weight loss results.
GLP-1 works by stimulating both GLP-1 and glucagon receptors on pancreatic beta cells, which leads to increased insulin release into the bloodstream. In clinical trials, GLP-1 Therapy was found to be safe and effective for reducing HbA1c levels by up to 1.7%.
GLP-1 Therapy also has been proven to improve beta cell function and reduce fasting plasma glucose levels compared with placebo. Additionally, GLP-1 therapy has been found to lower triglycerides and non-HDL cholesterol levels while increasing HDL cholesterol levels in diabetic patients. GLP-1 Therapy may offer a unique advantage over other treatments for diabetes as it can be used alone or in combination with existing medications such as metformin or sulfonylureas.
The dual receptor agonism of GLP-1 Therapy allows for greater control over insulin secretion and glycemic control without the additional risk of hypoglycemia or weight gain typically associated with traditional therapies. GLP-1 Therapy has quickly become a promising option for those looking for an effective way to manage their weight and better their health.
GLP-1 is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It works by regulating insulin and glucagon, leading to reduced appetite, delayed gastric emptying, and improved glucose control, all contributing to weight loss.
Your weight loss depends on many biologic factors including the duration and dosages that you receive. While individual results may vary, customers may potentially achieve weight loss targets of up to 30 pounds in the first three months of treatment, and possibly 50 pounds after 6 months. In a 72-week trial in participants with obesity, 5 mg, 10 mg, or 15 mg of GLP-1 once weekly provided substantial and sustained reductions in body weight of up to 20%.
GLP-1 comes in the form of a sterile liquid solution that is administered via subcutaneous injection once a week. It starts with a titrate to reduce side effects.
Dosages of GLP-1 (Compound 2 Receptor) for weight loss vary and are determined based on individual factors. Healthcare providers will prescribe an appropriate dosage, often titrated up gradually to achieve optimal results while minimizing potential side effects.
(most patients never go above 10 Milligrams)
Given the theoretical risk, GLP-1 (Compound 2 Receptor) should be avoided in those with a personal or family history of medullary thyroid carcinoma. Patients with a history of MEN 2 (multiple endocrine neoplasia syndrome type-2) should also avoid GLP-1.
All Rights Reserved | Primary Peak Medical Care